ALKSV — Alkermes Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeLarge CapNeutral

Annual balance sheet for Alkermes, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	539	535	635	536	608
Net Total Accounts Receivable
Net Total Receivables	300	265	290	327	297
Total Inventory
Prepaid Expenses
Total Current Assets	983	962	1,111	1,062	1,130
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	310	375	482	457	441
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,825	1,805	1,950	2,024	1,964
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	340	391	438	471	498
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	654	720	883	912	920
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	1,171	1,085	1,067	1,113	1,044
Total Liabilities & Shareholders' Equity	1,825	1,805	1,950	2,024	1,964
Total Common Shares Outstanding